Aft Forsyth & Sober’s Amgen AMGN Stock Holding History

Aft Forsyth & Sober’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-175	Closed	-$41K	–	32
2020 Q2	$41K	Buy	+175	New	+$39.9K	0.29%	45
2020 Q1	–	Sell	-390	Closed	-$94K	–	25
2019 Q4	$94K	Buy	+390	New	+$86K	0.09%	39

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Aft Forsyth & Sober's AMGN Position: Q3 2020 in Review

Aft Forsyth & Sober sold out of Amgen (AMGN) in Q3 2020, closing a stake of 175 shares — an estimated $41K sold.

Aft Forsyth & Sober first reported a position in AMGN in Q4 2019 and held it in 2 quarters. The position peaked at $94K in Q4 2019. 2,127 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

Aft Forsyth & Sober reported no remaining Amgen position as of Q3 2020 after selling out during the quarter.
Aft Forsyth & Sober sold 175 Amgen shares in Q3 2020, an estimated $41K.
Aft Forsyth & Sober first reported a position in Amgen in Q4 2019 and held it in 2 quarters.
Aft Forsyth & Sober's Amgen position peaked at $94K in Q4 2019.
2,127 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Aft Forsyth & Sober's 13F filing for Q3 2020, filed 14 Oct 2020.